| Gene: | HDAC9 |
| GeneID: | ENSG00000048052 |
| Chrom: | 7 |
| Start position: | 18086949 |
| End position: | 19002416 |
| Pathway: | Neutrophil extracellular trap formation |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.0796434 |
| Number of nsSNPs: | 4 |
| nsSNPs in gene: | rs149315720 rs4721715 rs4721716 rs6973063 |
| Gene Structure: |  |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.11 | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| Functional class: | Epigenetic |
| JensenLab PubMed score: | 185.17 (Percentile rank: 80.88%) |
| PubTator score: | 558.95 (Percentile rank: 94.00%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | |